Partin | search
Click here to view Partin news from 60+ newspapers.
Bookmark or Share- Prostate Cancer Nomograms - Memorial Sloan Kettering Cancer CenterThis tool is designed to calculate the likelihood of having high-grade prostate cancer in men who have been considered eligible for prostate biopsy by a urologist.
- An updated prostate cancer staging nomogram (Partin tables) based on ...Results. The median PSA was 4.9 ng/mL, 63% had Gleason 6 disease, and 78% of men had T1c disease. 73% of patients had OC disease, 23% had EPE, 3% had SV+ but not LN+, and 1% had LN+ disease. Compared to the previous Partin nomogram, there was no change in the distribution of pathologic state.
- Partin Tables | Johns Hopkins Brady Urological InstituteThe Partin Tables use clinical features of prostate cancer – Gleason score, serum PSA, and clinical stage – to predict whether the tumor will be confined to the prostate. The tables are based on the accumulated experience of urologists performing radical prostatectomy at the James Buchanan Brady Urological Institute.
- Prostate Cancer Stages | Johns Hopkins MedicinePartin Nomogram. Your doctor may use the Partin tables to predict your pathologic stage. The new Partin nomogram defines pathologic stages as: Organ-confined (OC) prostate cancer: This describes cancer found within the prostate gland.
- Partin Nomogram | Johns Hopkins Brady Urological InstituteEnter PSA, clinical stage and Gleason score to estimate the likelihood of each pathological stage of prostate cancer. The Partin Nomogram is a risk assessment tool from Johns Hopkins experts.
More
